In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — ...

We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.

Isolated improvements rarely translate into enterprise-wide transformation when they are layered onto outdated, inefficient ...

GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

Epic faced an FTC antitrust probe this week, but that didn't stop the EHR giant from unveiling a wave of new AI tools at its ...

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory ...

HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and ...

Employers expect healthcare costs to rise 9.2% in 2027 as they seek ways to curb rising hospital and pharmacy costs.

Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the ...

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder ...